Back to Journals » Research and Reports in Tropical Medicine » Volume 11

In vitro Effects of Punica granatum Ellagitannins on Adult Worms of Schistosoma mansoni

Authors Abozeid KH, El-Badawy MF, Mahmoud S, Shohayeb MM 

Received 6 February 2020

Accepted for publication 22 July 2020

Published 5 October 2020 Volume 2020:11 Pages 73—80

DOI https://doi.org/10.2147/RRTM.S248604

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Mario Rodriguez-Perez



Khalid H Abozeid, 1 Mohamed F El-Badawy, 2, 3 Soheir Mahmoud, 4 Mohamed M Shohayeb 5

1Department of Microbiology, College of Medicine, Taif University, Taif, Kingdom of Saudi Arabia; 2Department of Microbiology and Immunology, Faculty of Pharmacy, University of Sadat City, Sadat City, Menoufia Governorate, Egypt; 3Division of Pharmaceutical Microbiology, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Kingdom of Saudi Arabia; 4Parasitology Department, Theodor Bilharz Research Institute, Imbaba, Giza, Egypt; 5Department of Microbiology and Biotechnology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt

Correspondence: Khalid H Abozeid; Mohamed F El-Badawy Email [email protected][email protected]

Abstract: Schistosomiasis ranks second behind malaria in terms of overall morbidity and mortality. We evaluated the lethal effect of Punica granatum ellagitannins, extracted from the fruit rind, placenta and barks of the root and stem, on adult worms of Schistosoma mansoni (S. mansoni). All four ellagitannins were lethal to S. mansoni adult worms. However, while the rind ellagitannins were the most potent, placental ellagitannins were the least. Rind ellagitannins were capable of killing 40% of adult worms at a concentration of 25μg/mL after 5 days. The killing of 100% of the worms was achievable by rind ellagitannins at a concentration of 50μg/mL after 5 days. The LD 50S of the rind ellagitannins after 96h and 120h were 41.25 μg/mL and 28.73 respectively. Ellagitannins-treated worms suffered from erosions, wrinkles, swellings and losses, degenerations of the surface tubercles and tegument. In addition, ellagitannins induced deformation and degradation of oral and ventral suckers and degenerations in the muscles of worms. Ellagitannins also caused a separation of coupled worms and reduction of their motility. Data obtained suggest that ellagitannins of pomegranate could be considered as a cheap candidate for the treatment of schistosomiasis.

Keywords: Punica granatum, ellagitannins, Schistosoma mansoni, tegument, praziquantel

Introduction

Human schistosomiasis is one of the neglected tropical diseases caused by an intravascular blood-dwelling fluke.1 Most human infections are caused by S. mansoni, S. haematobium and S. japonicum, which are endemic in African, Asian and South American countries.1

It was estimated that more than 230 to 250 million people are infected annually with schistosoma and 779 million are at risk of getting an infection. On the other hand, about 280,000 annually die as a result of schistosomiasis worldwide.2

In the Middle East and North Africa region alone about 12.7 million individuals are infected with Schistosoma.3 S. mansoni, causes an annual infection of 54 million and 393 million are at risk of infection .4

Schistosomiasis has been greatly reduced in Middle East countries like Saudi Arabia, Morocco and Egypt. In Saudi Arabia the control of schistosomiasis has reduced the incidence of infection to 0.1% in 2003 and 0.02% in 2010. Areas of risk are restricted to Asir in the south-western region of Saudi Arabia.3 In 2012, the incidence of schistosomiasis was reduced to ˂3% in most villages.3

Praziquantel is a safe, effective, and cheap drug, which was released in 1979. In 2002, the World Health Organization sponsored its use during pregnancy and lactation.5 Praziquantel causes Ca2+ influx leading to spastic paralysis of adult worms. In addition, it causes rapid vacuolization of the worm surface.6 Praziquantel has been used in integrated control programmes of massive treatment of people in high-risk areas. It is given as a single oral dose for the treatment of all human Schistosoma spp. According to the world Health Organization, at least 290.8 million people required preventive treatment for schistosomiasis in 2018, out of which more than 97.2 million people were treated.7

The long-term worldwide application of praziquantel has led to the appearance of praziquantel-tolerant schistosomes in Senegal.8 On the other hand, in Egypt, where praziquantel has been extensively used, 1–2.4% of the treated villagers were not cured even after repeated administration of high doses of the drug.9 Schistosomes obtained from those individuals were tolerant to 3 times higher doses than the reference control isolates.10 More other reports have been published indicating failures of praziquantel treatment.11,12

The emerging of S. mansoni with reduced susceptibility to praziquantel in different infected human populations would have negative implications on the control programmes of schistosomiasis. Therefore, there has been an emphasis on the importance of finding alternatives to praziquantel.12,13

Punica granatum (P. granatum) is traditionally used for a wide variety of diseases, such as kidney problems, diarrhea, dysentery, hyperacidity, piles and cough.14 P. granatum extracts also possess antioxidant, anticancer and anti-inflammatory properties.14 Experimental data suggest that extracts of different parts of pomegranate are useful in the treatment and prevention of cancer, cardiovascular disease, diabetes, dental conditions, erectile dysfunction, bacterial infections, infertility, Alzheimer’s disease, arthritis, and obesity.14,15

P. granatum is rich in polyphenols like ellagitannins which are the major element of pomegranate extracts and they are responsible for its biological activities.16

P. granatum extracts were proved to be active against different parasites. For instance, Entamoeba histolytica is killed with IC50 of < 30µg/mL pomegranate extracts.17 Extracts of the peel of P. granatum were reported to have anti-coccidial properties in both mice and Japanese quail.18,19 In vitro and in vivo anthelmintic effect of pomegranate leaves and stem bark extracts were lethal to S. mansoni adult worms.19 The P. granatumextracts was significantly found to reduced the number and diameter of hepatic granulomas, decrease the number of schistosomal eggs in liver tissues, lowerthe liver inflammatory infiltration, and decrease the hepatic fibrosis in mice.20

In previous studies, we demonstrated the lethal effect of P. granatum ellagitannins against both miracidia and cercariae of S. mansoni.21,22 In this study, we investigated the lethal effect of ellagitannins of P. granatum on adult worms of S. mansoni. Data obtained suggest that P. granatum ellagitannins affect the viability, morphology and histology of S. mansoni adult worms.

Methods

Ethical and Legal Approval

Ethical and legal approval was obtained from the Deanship of Scientific Research at Taif University prior to the commencement of the study. All experiments were performed following the regulations of Taif University and the Saudi national guidelines for scientific research.

Preparation of Pomegranate Parts for Extraction

Fruit rind and placenta, stem bark and root barks of P. granatum were collected from pomegranate fruits and small trees grown in Taif farms, Saudi Arabia. All parts were air-dried at room temperature in the laboratory. The dried parts of the plant were ground by an electric blender.

Extraction and Separation of Ellagitannins

The powdered rind, placenta, stem and root barks were percolated in water overnight in a shaking incubator. XAD-16 (Sigma, USA) resin washed with methanol was packaged into a glass column and equilibrated with water. Aqueous extracts were applied to the column. The resin was washed with water and the adsorbed ellagitannins were eluted with methanol. Methanol was evaporated at 50ºC in a rotary vacuum evaporator and kept at −20°C until used.23

Preparation of Cercariae

Cercariae of S. mansoni NMRI strain were prepared from infected Biomphalaria alexandrina snails purchased from Theodor Bilharz Research Institute (Giza, Egypt). The snails were exposed to artificial light at 25°C to release cercariae which were used directly after shedding to infect mice.24

Mice Infection

Male WF1-albino mice aging 6–8 weeks and weighing 25–35g were obtained from King Fahd Specialist Medical Centre, Jeddah, KSA. They were kept in wire-mesh polycarbonate cages with autoclaved bedding. Mice had free access to food and water. All animal procedures were done in accordance with the ethical standards of Taif University and were approved by the Animal Experimentation Ethics Committee.

Adult male mice were infected according to the method of Olivier and Stirewalt.25 Briefly mice were individually placed in mouse-retaining chambers which allowed the tails to be immersed into tubes containing 100 cercariae in de-chlorinated tap water for 1h. The tails were removed and allowed to dry.

Isolation and in vitro Treatment of Adult S. mansoni Worms with Ellagitannins

Adult worms were recovered and cultured in vitro as previously described,26 with some modifications. Briefly, infected mice after being exposed to cercariae by 6 weeks were killed by cervical dislocation and dipped in 10% ethanol to minimize contamination. Portal and mesenteric vessels were perfused with sterile normal saline, and the adult worm pairs were removed aseptically from the mesenteric veins. Worms were washed with sterile phosphate buffer and cultured in 12 well plates containing RPMI 1640 medium (Sigma, USA) supplemented with penicillin (100 U/mL), streptomycin (100 µg/mL), 10% foetal calf serum (Gibco, USA), 2g/L glucose, 0.39g/L glutamate, and 20g/L NaHCO3.

Tannins were dissolved in sterile distilled water and added at the desired concentrations to the cultured worms in a final volume of 2 mL. Worms cultured in RPMI 1640 medium without the addition of tannins served as positive control. The plates were incubated in 5% CO2 atmosphere at 37°C. The worms were kept for 5 days and monitored for their motor activity (motility), pairing and viability every 24h under a dissecting microscope. Death of the worms was defined with the absence of movement for at least two minutes from the examination.

Scanning Electron Microscopy

Adult worms were fixed in 4% glutaraldehyde in cacodylate buffer, pH 7.4, for two hours and washed by the same buffer. The worms were then post-fixed in 2% Osmic acid and washed in cacodylate buffer. Finally, worms were dehydrated with increasing concentrations of ethanol. Specimens were mounted on stubs coated with gold and examined with a Joel JEM-1200 EXII electron microscope (Japan).27

Histopathological Investigation of the Recovered Worms

Worms were mounted with 70% ethanol, fixed in Bouin’s solution, and dehydrated by passage through increasing concentrations of alcohol. The worms were cleared with xylene, embedded in paraffin wax and finally, thin sections were prepared by a microtome. The sections were rehydrated and stained with hematoxylin and Eosin. The stained sections were dehydrated, cleared with xylene and mounted under a coverslip with Canada balsam. The sections were examined under the light microscope using the oil immersion lens.28

Statistical Analysis

All experiments were done in triplicates and values of mean ±standard deviation were compared using Students t-test. The statistical analysis of data was carried out using SPSS 16 statistical software programme.29

Results

Effects of P. granatum Ellagitannins on Adult Worms of S. mansoni

S. mansoni adult worms were exposed to three concentrations of P. granatum ellagitannins prepared from rind, stem, root and placenta for 120h. Throughout the experiment, the control female and male worms were viable and actively moving under the microscope.

Ellagitannins, at all the tested concentrations, caused a separation of the coupled worms and a reduction in their motor activity (data not shown).

The killing of 100% of the adult worms of S. mansoni was achievable by all the four investigated ellagitannins at 100µg/mL after 5 days. However, generally speaking, the ellagitannins of the rind was more active than other ellagitannins (Figure 1).

Figure 1 Lethal effect of P. granatum ellagitannins on Schistosoma mansoni adult worms after different time intervals.

While at 25µg/mL, ellagitannins of the stem and placenta failed to kill adult worms, rind and root bark were lethal to 40% of the adult worms after 5 days (Figure 1).

The rind and root ellagitannins killed 20% and 10% of the worms respectively after 3 days at a concentration of 50µg/mL. Only the rind ellagitannins were capable of killing 100% of the worms at a concentration of 50µg/mL after 5 days. However, the 100% mortality of worms was also achieved after only 3 days by rind ellagitannins at a concentration of 100µg/mL as shown in Figure 1.

Praziquantel was more active on schistosoma worms than ellagitannins. It killed 100% of the adult worms at all the tested concentrations (25, 50 and 100µg/mL) after 2 days.

The  LD50s of the rind were more significantly (P˂0.005) lower than the LD50s of the other tested ellagitannins which ranged between 75.31to 99.72µg/mL after 96h and 40.25 to 65.19µg/mL after 120h (Table 1).

Table 1 LD50 of Different Ellagitannins After 96 and 120 Hours

Scanning Electron Microscopy

Adult worms exposed to rind ellagitannins of P. granatum were examined by scanning electron microscope. Deformations and topographical changes of the tegument of the worms were observed compared to untreated worms as shown in Figure 2.

Figure 2 Scanning electron micrograph of adult male S. mansoni. (A) normal topography of the tegument; (B) P. granatum rind ellagitannins-treated adult male with degenerating tegumental changes; (C) normal tubercles of adult male S. mansoni; (D) distorted tubercles of adult male S. mansoni exposed to 50 µg/mL P. granatum rind ellagitannins for 72h; (E) normal appearance of oral and ventral suckers of untreated adult male S. mansoni; (F) oral and ventral suckers of adult male S. mansoni exposed to 50 µg/mL P.granatum rind ellagitannins for 72h. Arrows point to fusions of some edges of the gynaecophoric canal.

Worms treated with 50 µg/mL rind ellagitannins for 2 days suffered from alterations in the demography of the surface of the worms (Figure 2B). The tubercles were deformed and detached from the tegument and their remnants surrounded the treated worm (Figure 2B). The edges of the male gynaecophoric canal were fused at some sites as demonstrated in (Figure 2D and F). The surface of the deformed head of the worm was covered by corrugations and both the oral and ventral suckers were deformed, swelled and their surfaces were corrugated and wrinkled (Figure 2F).

Histopathological Investigation of Worms

Histopathological examination of adult male worms which were not exposed to P. granatum rind ellagitannins had intact tegument with normal intact tubercles which covered the surface of the tegument (Figure 3A). Both the sub-tegumental longitudinal and circular muscles were intact (Figure 3A). On the contrary, worms exposed to 50µg/mL of rind ellagitannins for 2 days suffered from tremendous degeneration and loss of tubercles of the tegument (Figure 3B and C). In addition, after 2 days in the presence of 50µg/mL rind ellagitannins, extensive degenerations of both the circular and longitudinal muscle tissues were observed with the appearance of vacuoles in both muscles (Figure 3B and C).

Figure 3 Histological sections of adult male worms of S.mansoni, stained by haematoxylin and eosin. The stained sections were examined using oil immersion lens of the light microscope. (A) untreated worms; (B) worm treated with 50µg/mL rind ellagitannins for 24 h; (C) worm treated with 50g/mL rind ellagitannins for 48h. Arrows point to tubercles (a), subtegumental circular musculature (b) and longitudinal musculature (c).

Discussion

Schistosomiasis ranks the second human parasitic diseases behind malaria in terms of overall morbidity and mortality.1,30 Praziquantel has been the drug of choice for schistosomiasis and millions of doses have been administered in control programmes in different countries.7 Therefore, there is a concern about the possibility of the appearance of praziquantel-resistant schistosomes.31 Consequently, there is an urgent need for the discovery of cheap and safe alternatives for praziquantel. P. granatum is an edible plant and its tannins have been used safely for thousands of years in folk medicine.14,15 In this study, ellagitannins extracted from the fruit rind, placenta and the barks of the root and stem of P. granatum were tested for their lethal effect on S. mansoni adult worms. Both pomegranate rind extracts and its high contents of ellagitannins are quite safe. Human overweight volunteers took safely tableted 1.42g/day pomegranate fruit extract for 28days without adverse effects.33 On the other hand, the oral LD50 of pomegranate fruit extract standardized to 30% punicalagin, which is one of the major ellagitannins, was greater than 5g/kg body weight.32 In addition, the intraperitoneal LD50 of the extract for rats was 217mg/kg body weight and 187mg/kg for mice.32

In this study, adult worms were exposed in vitro to different concentrations of ellagitannins extracts for 120h. No detrimental effects were observed during the duration of the experiments on untreated worms as revealed under the microscope. Some other researchers examined the schistosoma worms in vitro for 120h34 and 168h35 without reporting any detrimental effects.

All the tested ellagitannins in this study were lethal to S. mansoni worms, particularly the rind ellagitannins which killed 40% of the adult worms after 5 days at a concentration of 25µg/mL. The 100% killing of worms was achievable when the worms were exposed to 50 µg/mL and 100µg/mL for 120h and 72h respectively. The values of LD50 of the ellagitannins were 41.25µg/mL and 28.73µg/mL after 96h and 120h respectively. Therefore, the previously observed lethal effect of crude P. granatum extracts33 may be attributed, at least in part, to their contents of ellagitannins.

The tegument of schistosoma is a living anucleate and cytoplasmic structure. It is connected to the underlying nucleated cells that are located beneath the circular and longitudinal musculature. The tegument plays a critical role in the worm. It is essential for secretion and absorption of nutrient, protection from host immune response and it is an important target for anti-schistosomal drugs.34

In this study, ellagitannins caused marked changes in the topography of the worm’s tegument. The tegument of the worms treated with ellagitannins suffered from erosions, wrinkling, swellings, loss and degeneration of the surface of tegument and the tubercles. The severe damaging effect of the ellagitannins was noticed on adult worms after 48–72h. Tegumental changes were previously observed in adult worms treated with crude alcoholic extracts of the stem bark, rind and leaf of pomegranate.20,33 Crude extracts of pomegranate leaf and stem bark caused separation of the worm couples and decreased worm’s motility.20 Our data suggest that these reported tegumental changes and the separation of worm couples are probably, at least in part, due to the ellagitannins of the pomegranate.

On the other hand, the histopathological investigation of the treated worms revealed a severe degeneration in the musculature of the worm. The alterations of the schistosomal tegument by various natural and synthetic antischistosomal drugs have been previously reported. Examples of these natural and synthetic drugs are artemether,35 astiban,36 amoscanate,37 hycanthone,38 niridazole,39 aspidine and flavaspidic acid purified from the rhizomes of Dryopteris species,40 artesunate,41 mirazid purified from myrrh oleo-resin42 and ginger aqueous extract,43 oxamniquine44 and praziquantel.10

In this study, ellagitannins led also to the release of tegumental blebs. This phenomenon was previously observed when schistosomes were exposed to oxamniquine40 and ginger extracts.43 However, a unique phenomenon which was noticed in this study was the fusion of the edges of the gynaecophoric canal at some sites. This might be behind the uncoupling of worms which was observed in this study and was also caused by crude pomegranate extracts in another study.20

The consequences of the severe damages of the tegument which were noticeable as early as 48h, on the ability of the worm to survive in presence of ellagitannins are complex. The damage of the tegument, which was obvious as early as 48h, would presumably inhibit the ability of worms to disguise the immune system and the worm would become more vulnerable to the immune response of the host. Consequently, ellagitannins would likely facilitate the ability of host inflammatory cells to attack worms. Ellagitannins of pomegranate are known to enhance the innate immune system45 as praziquantel does.46 Therefore, ellagitannins of P. granatumwould additionally help the host to eradicate the already vulnerable worms. On the other hand, the damage of the tegument would also render the worms morevulnerable to host oxidant challenges. Peroxidation of the membranes of the tegument would cause further damages and further losses of its integrity.47 In schistosoma, glucose is mostly absorbed by the tegument and most of the ATPase activity is located in the tegument.48 Therefore, the damage of the tegument would be on the expense of the feeding of worms and the production of energy.49

Schistosoma worms use tubercle spines, and suckers to hold to blood capillaries. The observed severe damages of tubercle spines and suckers by ellagitannins might cause the worm to be dislodged by the blood flow.50

In this study, ellagitannins caused degeneration of the sub-tegumental layers of longitudinal and circular muscles. Similar observations were previously reported in S. mansoni, treated with praziquantel51 and artemether.35 The observed damages of muscles might explain the observed decrease in the activity and motility of treated worms.

The exact mechanism of the degenerative effect of ellagitannins of pomegranate on the tegument of the adult worms of schistosoma needs further investigation. Generally speaking, different phytochemicals have been reported to affect gene expression.5254 Ellagitannins like ellagic acid and punicalagin were reported to inhibit the promoter of the matrix metallopeptidase-9 (MMP-9) of the THP-1 cell line.55 Also pomegranate fruit extracts which are rich in ellagitannins reduced the proliferation of the breast cancer MCF-7 cells by the up regulation of 505 genes and the down regulation of other 398 genes.56 Therefore, the damaging and lethal effects of ellagitannins on the adult worms of schistosoma might be attributed at least in part to the down/upregulation of some vital genes for the parasite. On the other hand, pomegranate ellagitannins were reported to have inhibitory effect on some vital enzymes like rat intestinal α-glucosidase, porcine α-amylase57 and the vertebrate squalene epoxidase.58 Therefore, there is a possibility that pomegranate ellagitannins might inhibit some enzymes which are vital for the synthesis and/or integrity of the tegument.

Conclusion

It may be concluded that ellagitannins of P. granatum are lethal to S. mansoni. They caused severe damages to the tegument of the worms, affect their suckers, damaged their circular and longitudinal muscles and impair their motor activity. These effects are expected to cause schistosoma worms to be vulnerable to the immune system of the host. In a previous study, the oral administration of pomegranate crude peel extract, for three consecutive days, 45 days post- schistosomal infection, resulted in the death of 72.2% of adult worm.32 Therefore, we are currently evaluating the in vivo effect of purified ellagitannins on mice suffering from schistosomiasis.

Acknowledgment

The authors are grateful to Taif University, for its financial support for the project 5288/437/1, and for providing all the required research facilities. Also the authors are grateful for the division of Microbiology and Immunology at Department of Pharmaceutics and Industrial Pharmacy,College of Pharmacy, Taif University.

Disclosure

The authors declare that there is no conflicts of interest regarding the publication of this paper.

References

1. Lo NC, Addiss DG, Hotez PJ, et al. A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now. Lancet Infect Dis. 2017;17(2):e64–e69. doi:10.1016/S1473-3099(16)30535-7

2. Nelwan ML. Schistosomiasis: life cycle, diagnosis, and control. Curr Ther Res. 2019;91:5–9. doi:10.1016/j.curtheres.2019.06.001

3. Barakat R, El Morshedy H, Farghaly A. Human schistosomiasis in the Middle East and North Africa region. In: Neglected Tropical Diseases-Middle East and North Africa. Vienna: Springer; 2014:23–57.

4. World Health Organization, Current estimated total number of individuals with morbidity and mortality due to Schistosomiasis haematobium and S. Mansoni infection in Sub-Saharan Africa, Available from: https://www.who.int/schistosomiasis/epidemiology/table/en/. Accessed April 28, 2020.

5. Friedman JF, Olveda RM, Mirochnick MH, Bustinduy AL, Elliott AM. Praziquantel for the treatment of schistosomiasis during human pregnancy. Bull World Health Organ. 2018;96(1):59. doi:10.2471/BLT.17.198879

6. Park SK, Gunaratne GS, Chulkov EG, et al. The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel. J Biol Chem. 2019;294(49):18873–18880. doi:10.1074/jbc.AC119.011093

7. World Health Organization. Schistosomiasis. Available from: https://www.who.int/en/news-room/fact-sheets/detail/schistosomiasis. Accessed 28 April 2020.

8. Stelma F, Talla I, Sow S, et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg. 1995;53(2):167–170. doi:10.4269/ajtmh.1995.53.167

9. Ismail M, Metwally A, Farghaly A, Bruce J, Tao L-F, Bennett JL. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg. 1996;55(2):214–218. doi:10.4269/ajtmh.1996.55.214

10. Fallon P, Fookes R, Wharton G. Temporal differences in praziquantel-and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy. Parasitology. 1996;112(1):47–58. doi:10.1017/S0031182000065069

11. Maule AG, Marks NJ. Parasitic Flatworms: Molecular Biology, Biochemistry, Immunology and Physiology. CABI; 2006.

12. Mutapi F, Rujeni N, Bourke C, et al. Schistosoma haematobium treatment in 1–5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl Trop Dis. 2011;5(5):e1143. doi:10.1371/journal.pntd.0001143

13. Wang W, Wang L, Liang Y-S. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res. 2012;111(5):1871–1877. doi:10.1007/s00436-012-3151-z

14. Jurenka J. Therapeutic applications of pomegranate (Punica granatum L.): a review. Alter Med Rev. 2008;13:2.

15. Jasuja ND, Saxena R, Chandra S, Sharma R. Pharmacological characterization and beneficial uses of Punica granatum. Asian J Plant Sci. 2012;11(6):251. doi:10.3923/ajps.2012.251.267

16. Menezes SM, Cordeiro LN, Viana GS. Punica granatum (pomegranate) extract is active against dental plaque. J Herb Pharmacother. 2006;6(2):79–92. doi:10.1080/J157v06n02_07

17. Calzada F, Yépez-Mulia L, Aguilar A. In vitro susceptibility of Entamoeba histolytica and Giardia lamblia to plants used in Mexican traditional medicine for the treatment of gastrointestinal disorders. J Ethnopharmacol. 2006;108(3):367–370. doi:10.1016/j.jep.2006.05.025

18. Dkhil MA. Anti-coccidial, anthelmintic and antioxidant activities of pomegranate (Punica granatum) peel extract. Parasitol Res. 2013;112(7):2639–2646. doi:10.1007/s00436-013-3430-3

19. Berto BP, Borba HR. dos Santos HLC, et al. Evaluation of pomegranate (Punica granatum) pericarp aqueous extract on Eimeria spp. from Japanese quails (Coturnix japonica). Int J Vet Sci Med. 2014;2(1):35–40. doi:10.1016/j.ijvsm.2014.02.002

20. Yones DA, Badary DM, Sayed H, Bayoumi SA, Khalifa AA, El-Moghazy AM. Comparative evaluation of anthelmintic activity of edible and ornamental pomegranate ethanolic extracts against Schistosoma mansoni.. Biomed Res Int. 2016; 2016:2872708. doi:10.1152/ajplegacy.1975.229.3.746.

21. Abozeid K, Shohayeb M, Ismael A. In vitro tests for efficacy of tannins extracted from pomegranate (Punica granatum) against Schistosoma mansoni miracidia. J Sci Technol. 2012;13(1):55–65.

22. Zeid KHA, El-Badawy MF, Gumaa SA, Ismael A, Shohayeb MM. In vitro lethal effect of ellagitannins of the fruit rind of Punica Granatum and stem and root alkaloids on the miracidia and cercariae of Schistosoma mansoni. IOSR J Pharm Biol Sci. 2016;11(6):80–88.

23. Seeram N, Lee R, Hardy M, Heber D. Rapid large scale purification of ellagitannins from pomegranate husk, a by-product of the commercial juice industry. Separation Purificat Technol. 2005;41(1):49–55. doi:10.1016/j.seppur.2004.04.003

24. Perrett S, Whitfield P. In vitro cercaricidal activity of schistosomiasis. J Parasitol. 1996;52:617.

25. Olivier L, Stirewalt M. An efficient method for exposure of mice to cercariae of Schistosoma mansoni. J Parasitol. 1952;38(1):19–23. doi:10.2307/3274166

26. de Moraes J, Nascimento C, Lopes PO, et al. Schistosoma mansoni: in vitro schistosomicidal activity of piplartine. Exp Parasitol. 2011;127(2):357–364. doi:10.1016/j.exppara.2010.08.021

27. Dajem SMB, Mostafa O. Scanning electron microscopical studies on Schistosoma mansoni cercariae exposed to ultraviolet irradiation. Austr J Basic Appl Sci. 2007;1(4):776–784.

28. Bancroft J, Stevens A, Turner D. Theory and Practice of Histological Techniques. 4th ed. Madrid, Sanfrancisco, New York Edinburgh: Churchill Living Stone; 1996.

29. Levesque R. SPSS Programming and Data Management: A Guide for SPSS and SAS Users. SPSS; 2005.

30. Mutengo MM, Mwansa JC, Mduluza T, Sianongo S, Chipeta J. High Schistosoma mansoni disease burden in a rural district of western Zambia. Am J Trop Med Hyg. 2014;91(5):965–972. doi:10.4269/ajtmh.13-0612

31. Doenhoff MJ, Pica-Mattoccia L. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev Anti Infect Ther. 2006;4(2):199–210. doi:10.1586/14787210.4.2.199

32. Patel C, Dadhaniya P, Hingorani L, Soni MG. Safety assessment of pomegranate fruit extract: acute and subchronic toxicity studies. Food Chem Toxicol. 2008;46(8):2728–2735. doi:10.1016/j.fct.2008.04.035

33. Heber D, Seeram NP, Wyatt H, et al. Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size. J Agric Food Chem. 2007;55(24):10050–10054. doi:10.1021/jf071689v

34. Godinho LS, de Carvalho A, Soares L, et al. Anthelmintic activity of crude extract and essential oil of Tanacetum vulgare (Asteraceae) against adult worms of Schistosoma mansoni. Sci World J. 2014;201(460342):9.

35. Yepes E, Varela-M RE, Lopez-Aban J, Dakir EH, Mollinedo F, Muro A. In vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosine. PLoS One. 2014;9(10):e109431. doi:10.1371/journal.pone.0109431

36. Fahmy ZH, El-Shennawy AM, El-Komy W, Ali E, Hamid S. Potential antiparasitic activity of pomegranate extracts against shistosomules and mature worms of Schistosoma Mansoni: in vitro and in vivo study. Austr J Basic Appl Sci. 2009;3(4):4634–4643.

37. Thompson DP, Geary TG. The structure and function of helminth surfaces. In: Biochemistry and Molecular Biology of Parasites.  J. Joseph Marr and Miklós Müller, editors. Elsevier; 1995:203–232.

38. Shuhua X, Tanner M, N’Goran EK, et al. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop. 2002;82(2):175–181. doi:10.1016/S0001-706X(02)00009-8

39. Otubanjo OA. Schistosoma mansoni: astiban-induced damage to tegument and the male reproductive system. Exp Parasitol. 1981;52(2):161–170. doi:10.1016/0014-4894(81)90071-0

40. Voge M, Bueding E. Schistosoma mansoni: tegumental surface alterations induced by subcurative doses of the schistosomicide amoscanate. Exp Parasitol. 1980;50(2):251–259. doi:10.1016/0014-4894(80)90026-0

41. Hillman G, Gibler WB, Anderson J. Comparative effects of hycanthone in Schistosoma mansoni and Schistosoma japonicum. Am J Trop Med Hyg. 1977;26(2):238–242. doi:10.4269/ajtmh.1977.26.238

42. Popiel I, Erasmus DA. Schistosoma mansoni: niridazole-induced damage to the vitelline gland. Exp Parasitol. 1981;52(1):35–48. doi:10.1016/0014-4894(81)90058-8

43. Magalhães Filho A, De Melo M, Padovan PA, Padovan IP. Schistosoma mansoni: structural damage after treatment with oxamniquine. Mem Inst Oswaldo Cruz. 1987;82(Suppl 4):347–352. doi:10.1590/S0074-02761987000800067

44. Jiraungkoorskul W, Sahaphong S, Sobhon P, Riengrojpitak S, Kangwanrangsan N. Effects of praziquantel and artesunate on the tegument of adult Schistosoma mekongi harboured in mice. Parasitol Int. 2005;54(3):177–183. doi:10.1016/j.parint.2005.04.001

45. Hassan M, El-Motaiem M, Afify H, Abaza B, El-Shafei M, Massoud A. In vitro effect of Mirazid on Schistosoma mansoni worms. J Egypt Soc Parasitol. 2003;33(3):999–1008.

46. Mostafa OM, Eid RA, Adly MA. Antischistosomal activity of ginger (Zingiber officinale) against Schistosoma mansoni harbored in C57 mice. Parasitol Res. 2011;109(2):395–403. doi:10.1007/s00436-011-2267-x

47. Popiel I, Erasmus DA. Schistosoma mansoni: ultrastructure of adults from mice treated with oxamniquine. Exp Parasitol. 1984;58(3):254–262. doi:10.1016/0014-4894(84)90042-0

48. Harikrishnan R, Heo J, Balasundaram C, et al. Effect of Punica granatum solvent extracts on immune system and disease resistance in Paralichthys olivaceus against lymphocystis disease virus (LDV). Fish Shellfish Immunol. 2010;29(4):668–673. doi:10.1016/j.fsi.2010.07.006

49. Yegorov S, Joag V, Galiwango RM, et al. Schistosoma mansoni treatment reduces HIV entry into cervical CD4+ T cells and induces IFN-I pathways. Nat Commun. 2019;10(1):1–12. doi:10.1038/s41467-019-09900-9

50. LoVerde PT. Do antioxidants play a role in schistosome host–parasite interactions? Parasitol Today. 1998;14(7):284–289. doi:10.1016/S0169-4758(98)01261-7

51. Nechay BR, Hillman GR, Dotson MJ. Properties and drug sensitivity of adenosine triphosphatases from Schistosoma mansoni.. J Parasitol. 1980;66(4):596–600. doi:10.2307/3280515

52. Riad NH, Taha HA, Mahmoud YI. Effects of garlic on albino mice experimentally infected with Schistosoma mansoni: a parasitological and ultrastructural study. Trop Biomed. 2009;26(1):40–50.

53. Southgate V, Rollinson D, De Bont J, Vercruysse J, Van Aken D, Spratt J. Surface topography of the tegument of adult Schistosoma nasale Rao, 1933 from Sri Lanka. Syst Parasitol. 1990;16(2):139–147. doi:10.1007/BF00009612

54. Becker B, Mehlhorn H, Andrews P, Thomas H, Eckert J. Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro. Zeitschrift für Parasitenkunde. 1980;63(2):113–128. doi:10.1007/BF00927527

55. Wong F-C, Yong A-L, Sim K-M, Ong H-C, Chai -T-T. proteomic analysis of bacterial expression profiles following exposure to organic solvent flower extract of Melastoma candidum D Don (Melastomataceae). Trop J Pharm Res. 2014;13(7):1085–1092. doi:10.4314/tjpr.v13i7.11

56. Santiago C, Lim K-H, Loh H-S, Ting KN. Prevention of cell-surface attachment and reduction of penicillin-binding protein 2a (PBP2a) level in methicillin-resistant Staphylococcus aureus biofilms by Acalypha wilkesiana. BMC Complement Altern Med. 2015;15(1):1–7. doi:10.1186/s12906-015-0615-6

57. Shohayeb M, Halawani E. The effect of alkaloids, saponins and thymoquinone of nigella sativa seeds on biofilm production, motility, outer membrane proteins and lipopolysaccharide of some bacteria. Int J Advan Res. 2017;15:562–571. doi:10.21474/IJAR01/3186

58. Dell’Agli M, Galli GV, Bulgari M, et al. Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria. Malar J. 2010;9(1):208. doi:10.1186/1475-2875-9-208

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.